HK1254754A1 - 用於加工含有活細胞的生物藥物的方法 - Google Patents

用於加工含有活細胞的生物藥物的方法

Info

Publication number
HK1254754A1
HK1254754A1 HK18113797.8A HK18113797A HK1254754A1 HK 1254754 A1 HK1254754 A1 HK 1254754A1 HK 18113797 A HK18113797 A HK 18113797A HK 1254754 A1 HK1254754 A1 HK 1254754A1
Authority
HK
Hong Kong
Prior art keywords
methods
living cells
drugs containing
processing biological
containing living
Prior art date
Application number
HK18113797.8A
Other languages
English (en)
Inventor
Michael Har-Noy
Original Assignee
Immunovative Therapies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunovative Therapies Ltd filed Critical Immunovative Therapies Ltd
Publication of HK1254754A1 publication Critical patent/HK1254754A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0236—Mechanical aspects
    • A01N1/0263—Non-refrigerated containers specially adapted for transporting or storing living parts whilst preserving, e.g. cool boxes, blood bags or "straws" for cryopreservation
    • A01N1/0273—Transport containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B1/00—Packaging fluent solid material, e.g. powders, granular or loose fibrous material, loose masses of small articles, in individual containers or receptacles, e.g. bags, sacks, boxes, cartons, cans, or jars
    • B65B1/04—Methods of, or means for, filling the material into the containers or receptacles
    • G01N15/149—
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6866—Interferon
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/555—Interferons [IFN]
    • G01N2333/57—IFN-gamma
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30 CD40 or CD95
HK18113797.8A 2011-05-03 2014-09-16 用於加工含有活細胞的生物藥物的方法 HK1254754A1 (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201161481991P 2011-05-03 2011-05-03
US201161528493P 2011-08-29 2011-08-29
US201161565225P 2011-11-30 2011-11-30
US201261582878P 2012-01-04 2012-01-04

Publications (1)

Publication Number Publication Date
HK1254754A1 true HK1254754A1 (zh) 2019-07-26

Family

ID=47108026

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18113797.8A HK1254754A1 (zh) 2011-05-03 2014-09-16 用於加工含有活細胞的生物藥物的方法

Country Status (17)

Country Link
US (4) US10350242B2 (zh)
EP (1) EP2704741B1 (zh)
JP (3) JP5934783B2 (zh)
KR (3) KR102229108B1 (zh)
CN (2) CN108261423B (zh)
AU (1) AU2012250794B2 (zh)
BR (1) BR112013028257B1 (zh)
CA (1) CA2838041C (zh)
DK (1) DK2704741T3 (zh)
ES (1) ES2648136T3 (zh)
HK (1) HK1254754A1 (zh)
HU (1) HUE034995T2 (zh)
IL (1) IL229176B (zh)
PL (1) PL2704741T3 (zh)
PT (1) PT2704741T (zh)
SG (1) SG194774A1 (zh)
WO (1) WO2012151266A1 (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160095307A1 (en) * 2014-10-07 2016-04-07 NuTech Medical, Inc. Method and composition for hypothermic storage of placental tissue
WO2016075542A1 (en) * 2014-11-11 2016-05-19 Macrocure, Ltd. Methods for extended storage of activated leukocyte compositions
JP6814593B2 (ja) * 2016-10-14 2021-01-20 株式会社 バイオミメティクスシンパシーズ 幹細胞及び投与システム
WO2020114491A1 (en) * 2018-12-07 2020-06-11 Gracell Biotechnologies (Shanghai) Co., Ltd. Compositions and methods for immunotherapy
JP2022533949A (ja) * 2019-05-15 2022-07-27 ステムサイト インコーポレーテッド 高濃度細胞のパッケージングおよび輸送
EP4261242A1 (en) 2020-12-10 2023-10-18 Agc Inc. Oxyalkylene polymer, method for producing same, curable composition and cured product
JPWO2022191084A1 (zh) 2021-03-12 2022-09-15
JPWO2023282298A1 (zh) 2021-07-07 2023-01-12
WO2023190640A1 (ja) * 2022-03-30 2023-10-05 株式会社カネカ 細胞投与用シリンジを調製する方法、及び細胞投与用シリンジを用いた細胞輸送方法

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2439003A1 (fr) 1978-10-20 1980-05-16 Anvar Nouvelles pieces d'osteosynthese, leur preparation et leur application
US5766920A (en) 1982-08-11 1998-06-16 Cellcor, Inc. Ex vivo activation of immune cells
WO1988000970A2 (en) 1986-08-08 1988-02-11 Regents Of The University Of Minnesota Method of culturing leukocytes
ZA888978B (en) 1987-12-04 1990-07-25 Du Pont Immobilized interleukin 2 and interleukin 2 containing a carboxylterminal extension
US6534055B1 (en) 1988-11-23 2003-03-18 Genetics Institute, Inc. Methods for selectively stimulating proliferation of T cells
US6905680B2 (en) 1988-11-23 2005-06-14 Genetics Institute, Inc. Methods of treating HIV infected subjects
US6352694B1 (en) 1994-06-03 2002-03-05 Genetics Institute, Inc. Methods for inducing a population of T cells to proliferate using agents which recognize TCR/CD3 and ligands which stimulate an accessory molecule on the surface of the T cells
US5126132A (en) 1989-08-21 1992-06-30 The United States Of America As Represented By The Department Of Health And Human Services Tumor infiltrating lymphocytes as a treatment modality for human cancer
US5728388A (en) 1989-10-03 1998-03-17 Terman; David S. Method of cancer treatment
US6204058B1 (en) 1992-02-07 2001-03-20 Vasogen Ireland Limited Treatment of autoimmune diseases
AU5729294A (en) 1992-11-25 1994-06-22 Tanox Biosystems, Inc. Conjugates and constructs including anti-cd28 and anti-cd3 binding molecules
SG49113A1 (en) 1993-08-06 1998-05-18 Cytel Corp Methods for ex vivo therapy using peptide-loaded antigen presenting cells for the activation of ctl
IL107483A0 (en) 1993-11-03 1994-02-27 Yeda Res & Dev Bone marrow transplantation
US5827642A (en) 1994-08-31 1998-10-27 Fred Hutchinson Cancer Research Center Rapid expansion method ("REM") for in vitro propagation of T lymphocytes
DE69628154T2 (de) 1995-03-08 2004-03-18 The Scripps Research Institute, La Jolla Antigen präsentierendes system und aktivierung von t-zellen
DE19545257A1 (de) 1995-11-24 1997-06-19 Schering Ag Verfahren zur Herstellung von morphologisch einheitlichen Mikrokapseln sowie nach diesem Verfahren hergestellte Mikrokapseln
WO1997046256A1 (en) 1996-05-23 1997-12-11 The Scripps Research Institute Mhc class ii antigen-presenting systems and methods for activating cd4+ t cells
US5753506A (en) 1996-05-23 1998-05-19 Cns Stem Cell Technology, Inc. Isolation propagation and directed differentiation of stem cells from embryonic and adult central nervous system of mammals
EP0930887B1 (en) * 1996-10-11 2002-12-18 The Regents of the University of California Cancer immunotherapy using tumor cells combined with mixed lymphocytes
JP2001505114A (ja) 1996-12-03 2001-04-17 オステオバイオロジックス，インコーポレイテッド 生分解性ポリマー膜
EP0966523A1 (en) 1997-01-31 1999-12-29 Hemosol Inc. Method for the production of selected lymphocytes
US7282198B2 (en) * 1997-03-19 2007-10-16 The University Of Arkansas For Medical Sciences Immunotherapeutic methods targeted towards stratum corneum chymotryptic enzyme
WO1998053768A1 (en) 1997-05-30 1998-12-03 Osteobiologics, Inc. Fiber-reinforced, porous, biodegradable implant device
EP1030674A1 (en) 1997-11-10 2000-08-30 Arch Development Corporation METHODS FOR TREATMENT OF TUMORS AND TUMOR CELLS USING $i(EX VIVO) ACTIVATED T CELLS
JP2001054563A (ja) 1999-07-12 2001-02-27 Isotis Bv 縫合糸
US7112576B1 (en) 1999-12-10 2006-09-26 Regents Of The University Of Minnesota Compositions and methods for cryopreservation of peripheral blood lymphocytes
US20030119185A1 (en) * 2000-02-24 2003-06-26 Xcyte Therapies, Inc. Activation and expansion of cells
US6867041B2 (en) 2000-02-24 2005-03-15 Xcyte Therapies, Inc. Simultaneous stimulation and concentration of cells
AU4328801A (en) 2000-02-24 2001-09-03 Xcyte Therapies Inc Simultaneous stimulation and concentration of cells
US20020127208A1 (en) 2000-08-31 2002-09-12 Waller Edmund K. Method of transplantation using chemotherapy-treated allogeneic cells that enhance immune responses without graft versus host disease
US6626950B2 (en) 2001-06-28 2003-09-30 Ethicon, Inc. Composite scaffold with post anchor for the repair and regeneration of tissue
US20040258661A1 (en) 2001-10-31 2004-12-23 Daniel Fowler Generation of use of tc1 and tc2 cells
AU2002351277A1 (en) 2001-12-06 2003-07-09 Georgia Tech Research Corporation Biodegradable, porous structures useful for growing living tissue, and methods of manufacture
US20030170238A1 (en) * 2002-03-07 2003-09-11 Gruenberg Micheal L. Re-activated T-cells for adoptive immunotherapy
US20030175272A1 (en) 2002-03-07 2003-09-18 Medcell Biologics, Inc. Re-activated T-cells for adoptive immunotherapy
DE10230223A1 (de) 2002-07-04 2004-01-22 Tegenero Ag Mikropartikel mit CD28-spezifischen monoklonalen Antikörpern
US7402431B2 (en) 2004-03-01 2008-07-22 Immunovative Therapies, Ltd. T-cell therapy formulation
US7435592B2 (en) * 2003-05-13 2008-10-14 Immunovative Therapies, Ltd. Compositions for allogeneic cell therapy
US7371228B2 (en) 2003-09-19 2008-05-13 Medtronic Vascular, Inc. Delivery of therapeutics to treat aneurysms
US7592431B2 (en) 2004-02-26 2009-09-22 Immunovative Therapies, Ltd. Biodegradable T-cell Activation device
PT2573166T (pt) 2004-02-26 2016-07-07 Immunovative Therapies Ltd Métodos para preparar células-t para terapia celular
US7446099B2 (en) 2004-02-27 2008-11-04 Nitto Denko Corporation Compositions and methods for biodegradable polymer-peptide mediated transfection
WO2005084276A2 (en) 2004-03-01 2005-09-15 Immunovative Therapies, Ltd. Cell therapy formulation method and composition
CA2557436A1 (en) 2004-03-05 2005-09-29 The Trustees Of Columbia University In The City Of New York Polymer-ceramic-hydrogel composite scaffold for osteochondral repair
TW200726474A (en) * 2005-07-15 2007-07-16 Cognate Therapeutics Inc The immunophenotype and immunogenicity of human adipose derived cells
EP1792979A1 (en) * 2005-12-01 2007-06-06 Stiftung Caesar Center of Advanced European Studies and Research Cell culture system for the enrichment and expansion of stem cells
EP2259798B1 (en) * 2008-03-05 2013-12-11 Baxter International Inc. Surface-modified particles and methods for targeted drug delivery

Also Published As

Publication number Publication date
CA2838041A1 (en) 2012-11-08
US10350242B2 (en) 2019-07-16
BR112013028257B1 (pt) 2020-05-12
US20130101562A1 (en) 2013-04-25
JP2017039728A (ja) 2017-02-23
JP2014517830A (ja) 2014-07-24
CN108261423B (zh) 2021-01-08
AU2012250794B2 (en) 2015-11-05
ES2648136T3 (es) 2017-12-28
JP2015091848A (ja) 2015-05-14
AU2012250794A1 (en) 2013-12-12
KR20140099328A (ko) 2014-08-11
KR20140043367A (ko) 2014-04-09
US20230218672A1 (en) 2023-07-13
EP2704741B1 (en) 2017-08-23
JP6006288B2 (ja) 2016-10-12
JP5934783B2 (ja) 2016-06-15
DK2704741T3 (da) 2017-11-27
KR102229108B1 (ko) 2021-03-18
SG194774A1 (en) 2013-12-30
IL229176A0 (en) 2013-12-31
BR112013028257A2 (pt) 2017-01-17
CA2838041C (en) 2018-09-25
KR102202460B1 (ko) 2021-01-14
US20190350976A1 (en) 2019-11-21
KR20190090030A (ko) 2019-07-31
WO2012151266A1 (en) 2012-11-08
PL2704741T3 (pl) 2018-02-28
EP2704741A4 (en) 2014-11-19
EP2704741A1 (en) 2014-03-12
CN108261423A (zh) 2018-07-10
US20230226112A1 (en) 2023-07-20
AU2012250794A8 (en) 2013-12-19
IL229176B (en) 2020-03-31
PT2704741T (pt) 2017-11-24
JP6359059B2 (ja) 2018-07-18
US11648273B2 (en) 2023-05-16
CN103732247A (zh) 2014-04-16
HUE034995T2 (en) 2018-05-02

Similar Documents

Publication Publication Date Title
EP2714935A4 (en) SYSTEMS AND METHODS FOR GENETIC AND BIOLOGICAL ANALYSIS
EP2755019A4 (en) METHOD OF DETECTING BIOLOGICAL SUBSTANCE
SG10201602113TA (en) Systems And Methods For Biological Analysis
HK1254754A1 (zh) 用於加工含有活細胞的生物藥物的方法
EP2740026A4 (en) METHOD AND SYSTEMS FOR BIOLOGICAL DATA ANALYSIS
SG11201401919TA (en) Optical systems and methods for biological analysis
EP2613138A4 (en) PROCESS FOR DETECTION OF BIOLOGICAL SUBSTANCES
EP2649016A4 (en) PROCESSES FOR CONTINUOUS PROCESSING FOR BIOLOGICAL PRODUCTS
SG11201406039WA (en) Systems and methods for containing biological samples
EP2833144A4 (en) METHOD OF DETECTING BIOLOGICAL SUBSTANCE
EP2711682A4 (en) CLARIFICATION REAGENT FOR BIOLOGICAL MATERIALS AND USE THEREOF
GB2552128B (en) Biological sample collection device
GB201118753D0 (en) Biological sample collection device
EP2764112A4 (en) DIRECT NUCLEIC ACID ANALYSIS
GB201100150D0 (en) Mutational analysis
EP2780688A4 (en) APPARATUS FOR PROCESSING BIOLOGICAL SAMPLES
EP2802881A4 (en) DEVICE AND METHOD FOR HANDLING BIOLOGICAL TISSUES
GB201100282D0 (en) Biological methods
EP2686660A4 (en) ARRANGEMENT FOR STORING BIOLOGICAL SAMPLES
EP2860239A4 (en) VESSEL FOR BREEDING HUMAN ES CELLS
GB201020174D0 (en) Biological sample storage device
EP2705134A4 (en) SYSTEM AND METHOD FOR ANALYZING WHITE GLOBLES
GB201206148D0 (en) Tissue sample handling apparatus
SG11201401911XA (en) Systems and methods for biological analysis
SG11201404524WA (en) Methods for identifying agents with desired biological activity